|
⚲
|
| Keyboard |
| Mark Baum | |
|---|---|
| Firm | |
| Address | c/o Surface Ophthalmics, Inc 5000 Hopyard Road, Suite 402 Pleasanton, CA 94588 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Surface Ophthalmics Inc | 021-402408 | Director | 25.1 M of 30.6 M |
||
| Harrow Health Inc | 021-399461 | Executive Officer | 10.7 M of 10.7 M |
||
| Eton Pharmaceuticals Inc | 021-364522 | Director | 7.5 M of 7.5 M |
||
| Melt Pharmaceuticals Inc | 021-332805 | Director | 11.4 M of 25.8 M |
||
| Surface Pharmaceuticals Inc | 021-312944 | Executive Officer | 15.0 M of 20.0 M |
||
| Eton Pharmaceuticals Inc | 021-289651 | Director | 20.1 M of 20.1 M |
||
| Ideal Power Inc | 021-282908 | Director | 15.0 M of 15.0 M |
||
| Imprimis Pharmaceuticals Inc | 021-277423 | Executive Officer | 10.1 M of 10.1 M |
||
| Imprimis Pharmaceuticals Inc | 021-232341 | Executive Officer | 0.5 M of 0.8 M |
||
| Endra Inc | 021-214218 | Director | 0.3 M of 1.5 M |
||
| Ideal Power Inc | 021-201241 | Director | 0.8 M of 0.8 M |
||
| Imprimis Pharmaceuticals Inc | 021-177672 | Executive Officer | 7.9 M of 7.9 M |
||
| Shrink Nanotechnologies Inc | 021-135570 | Executive Officer | 0.3 M of 0.3 M |
||